In this article, we look at such activity from the ten companies that represent #6 through #15 on our list of the largest device companies ranked by revenue.
The influence of hospital VACs has created a market access risk that you must consider when assessing new technologies-before product development begins. How do you reduce that risk?
Value-based healthcare is driving today's business decisions, from people to place of surgery to product. The OMTEC 2017 opening Keynote Panel affirmed that fact as they predicted the companies and technologies that will lead orthopaedics in 2025.
Device companies are prioritizing supply chain alignment to achieve company vision, leverage expertise and obtain significant cost savings. For insight we turned to Jeoff Burris and Ken Jones, two thought leaders in this area, to show us how to accomplish these objectives.
The orthopaedic pediatric market is heating up, with new products, brands and companies emerging in the last three quarters. The segment is ripe for growth and possibly acquisition.
The Trillennium Man was made with 3D scans of knees, hips and shoulders compiled into morphs that show the change in joint shape over the last 350 million years, and what joints might look like 4,000 years from now.
Discussions at the 2017 AAOS Annual Meeting were dominated by the new era of joint reconstruction procedures and three prevailing topics: robotics, bundled payments and outpatient procedures. From our conversations with device companies, investors and surgeons, it's clear that companies that are able to capitalize on one or more of the shifts shaping this segment will be positioned to maintain or grow market share.
What's on the horizon for joint reconstruction? We posed that question to Orhun Muratoglu, Ph.D., a materials expert, as well as Director of the Harris Orthopaedic Laboratory and Director of the Technology Implementation Research Center (TIRC) at Massachusetts General Hospital.
AAOS President Gerald R. Williams Jr., M.D., offers perspective on prominent areas for near-term technology advancements. His five-year outlook aligns with hot topics of recent years.
The U.S. hospital landscape steadily continues to be shaped by consolidation that is forced by competition, declining reimbursement and public and private payor cost and control measures. As these trends are expected to endure at least through the next decade, it's imperative that you understand what your hospital customer base will look like several years from now.